- Home
- VIGL vs ZENV Comparison
VIGL vs ZENV Comparison
Compare VIGL & ZENV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VIGL
- ZENV
- Stock Information
- Founded
- VIGL 2020
- ZENV 2005
- Country
- VIGL United States
- ZENV Brazil
- Employees
- VIGL N/A
- ZENV N/A
- Industry
- VIGL Biotechnology: Pharmaceutical Preparations
- ZENV Computer Software: Prepackaged Software
- Sector
- VIGL Health Care
- ZENV Technology
- Exchange
- VIGL Nasdaq
- ZENV Nasdaq
- Market Cap
- VIGL 134.9M
- ZENV 79.2M
- IPO Year
- VIGL 2022
- ZENV 2021
- Fundamental
- Price
- VIGL $8.02
- ZENV $1.45
- Analyst Decision
- VIGL Buy
- ZENV
- Analyst Count
- VIGL 7
- ZENV 0
- Target Price
- VIGL $8.00
- ZENV N/A
- AVG Volume (30 Days)
- VIGL 1.4M
- ZENV 87.2K
- Earning Date
- VIGL 08-12-2025
- ZENV 07-02-2025
- Dividend Yield
- VIGL N/A
- ZENV N/A
- EPS Growth
- VIGL N/A
- ZENV N/A
- EPS
- VIGL N/A
- ZENV N/A
- Revenue
- VIGL N/A
- ZENV $181,911,572.00
- Revenue This Year
- VIGL N/A
- ZENV $8.58
- Revenue Next Year
- VIGL N/A
- ZENV $8.83
- P/E Ratio
- VIGL N/A
- ZENV N/A
- Revenue Growth
- VIGL N/A
- ZENV 23.99
- 52 Week Low
- VIGL $1.31
- ZENV $1.02
- 52 Week High
- VIGL $8.03
- ZENV $3.03
- Technical
- Relative Strength Index (RSI)
- VIGL 89.24
- ZENV 45.95
- Support Level
- VIGL $7.86
- ZENV $1.40
- Resistance Level
- VIGL $7.96
- ZENV $1.57
- Average True Range (ATR)
- VIGL 0.03
- ZENV 0.14
- MACD
- VIGL -0.16
- ZENV -0.01
- Stochastic Oscillator
- VIGL 83.33
- ZENV 9.60
About VIGL Vigil Neuroscience Inc.
Vigil Neuroscience Inc is a clinical-stage biotechnology company engaged in improving the lives of patients, caregivers, and families affected by rare and common neurodegenerative diseases by pursuing the development of disease-modifying therapeutics to restore the vigilance of microglia. Microglia are the sentinel immune cells of the brain and play a critical role in maintaining central nervous system (CNS) health and responding to damage caused by disease. The group provides solutions for fully human monoclonal antibody and Oral small molecule TERM2 agonist.
About ZENV Zenvia Inc.
Zenvia Inc provides a platform that enables companies to create journeys for their end customers across a variety of channels. The company operates in two reportable segments namely CPaaS and SaaS. It has a geographic presence in Brazil, the USA, Argentina, Mexico, and Others. The company generates the majority of its revenue from Brazil.